Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $35,632 - $63,222
301 Added 11.03%
3,030 $544,000
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $82,412 - $135,537
698 Added 34.37%
2,729 $323,000
Q4 2021

Feb 16, 2022

SELL
$225.82 - $368.51 $369,441 - $602,882
-1,636 Reduced 44.61%
2,031 $516,000
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $496,612 - $1.08 Million
-2,238 Reduced 37.9%
3,667 $1.41 Million
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $63,504 - $164,084
966 Added 19.56%
5,905 $617,000
Q3 2020

Nov 12, 2020

BUY
$54.34 - $94.85 $268,385 - $468,464
4,939 New
4,939 $349,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.